Hatch Medical

What Hatch Medical does

Hatch Medical, L.L.C. is a privately held medical device incubator and technology brokerage firm founded in 2000 by Paul Gianneschi and headquartered in Santa Rosa Beach, Florida. The firm operates a three-part platform serving physician inventors, medical device entrepreneurs, early-stage companies, and PE/VC acquirers in the minimally invasive device space, with an explicit therapeutic focus on peripheral, cardiovascular, and oncological disease states. Its device incubator provides project leadership, engineering, regulatory submission support, bench and clinical research coordination, and manufacturing oversight via ISO-certified partner networks in exchange for equity in physician-conceived projects—a risk-sharing model that allows the firm to advance technologies larger device companies might decline. Its technology brokerage arm functions like a boutique investment bank, intermediating the sale, licensing, or distribution of medical device assets, while its consulting arm delivers due diligence, valuation modeling, fairness opinions, market assessment, and distribution planning.

The firm's product portfolio spans both actively incubated technologies and previously brokered or divested assets. Current incubator/active products include the EN Snare® foreign body retrieval system (self-sizing device with three interlaced nitinol loops with platinum strands for fluoroscopic visualization), Fibrex® catheter patency device (tri-axial delivery with shaped-memory helical nitinol stripping coil for fibrin removal from central venous catheters), PortIO™ implantable intraosseous vascular access device (first subcutaneous long-term IO access without a reservoir), AdVENTage® bone marrow aspiration biopsy system (patented venting mechanism to reduce negative pressure), VascuTech Medical radial sheath line (4F–7F with proprietary Oculus™ hemostatic valve and Vapor™ transition-less thin-wall extrusion), and Scorpion® liver access systems. Divested or licensed assets include Clik-FIX catheter securement devices (sold to B. Braun Medical, 2022), EN Snare® (sold to Merit Medical Systems for $21 million, 2009), DriPAD™ liquid solidification technology (sold to Merit Medical), FlatCath™ low-profile hemodialysis catheter (licensed to InterV Medical), Novatek AAA stent-graft IP (sold to Endologix), Phase One Medical anchoring technology (sold to NDC), and B. Braun peripheral/carotid stent and embolic protection assets (brokered to Scion Medical).

Hatch Medical monetizes through a hybrid of one-time transaction/brokerage fees on asset sales and licensing deals, ongoing royalty streams from licensed technologies, equity participation in incubated projects that pays out on sale, license, or commercialization milestones, and professional services fees for due diligence, valuation, and consulting engagements. Pricing is quote-based and individually negotiated with no publicly disclosed fee schedules. The firm operates with a lean 1–10 employee base anchored by two principals (Gianneschi and Steven M. Hvozda, both C.R. Bard alumni), supplemented by a six-member Physician Advisory Council and an extended network of university teaching hospitals and ISO-certified manufacturing partners for catheter extrusion, nitinol wire forming, and injection molding. Recent strategic activity includes a 2024 joint venture with PAVmed/PMX for PortIO commercialization, brokered mandates for EndoBar Solutions, ADN International, and Fixit Medical, and ongoing co-development partnerships with Syncro Medical Innovations (2021) and VascuTech Medical (2020).

Name

Hatch Medical

Legal name

Hatch Medical, L.L.C.

Website

https://hatchmedical.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Hatch Medical is a privately held medical device incubator and technology brokerage firm assisting physician inventors and early-stage companies in commercializing minimally invasive peripheral, cardiovascular, and oncological devices through equity-based incubation, asset sale brokerage, and consulting services.

Ownership category

akta.pro rank

Headquarters

HQ city

Santa Rosa Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Device Incubation Services: Hatch Medical provides project leadership, industry expertise and resources to physician inventors in exchange for equity in physician-conceived projects. This risk-sharing model enables the company to take on projects that larger companies might reject without upfront costs or out-of-pocket expenses for inventors.
2. Technology Brokerage: Operating as a boutique investment bank, Hatch Medical assists clients with the sale, license or distribution of medical device assets. Revenue generated through successful transactions in the form of brokerage fees, success fees, or ongoing royalties from licensed technologies.
3. Consulting Services: Due diligence on prospective acquisition targets, target market assessment, focus groups, physician interviews, clinical product evaluations, business plan review, valuation modeling, and distribution planning. Revenue through professional services fees.
4. Engineering and Regulatory Support: Product engineering and design, bench top testing, regulatory submissions, clinical research, and manufacturing coordination through ISO certified partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Hatch Medical is a medical device incubator and technology brokerage firm that assists physician inventors, entrepreneurs, and early-stage companies with the commercialization of minimally invasive medical device technologies. The company provides three core services: (1) Device Incubator Services, offering project leadership and resources in exchange for equity through a risk-sharing model; (2) Technology Brokerage, operating as a boutique investment bank to facilitate the sale, license, or distribution of medical device assets; and (3) Consulting Services, providing due diligence, valuation, and distribution planning. Its focus areas are peripheral, cardiovascular, and oncological disease states.

Product overview

Hatch Medical is a medical device incubator and technology brokerage firm that operates as a three-part platform: (1) Device Incubator Services that assist physician inventors with product development in exchange for equity through a risk-sharing model; (2) Technology Brokerage that facilitates sale, license, or distribution of medical device assets similar to a boutique investment bank; and (3) Consulting Services covering due diligence, valuation, and distribution planning. The company's product portfolio includes developed and brokered devices such as the EN Snare® foreign body retrieval system, Fibrex® catheter patency device, PortIO™ implantable intraosseous vascular access device, AdVENTage® bone marrow biopsy system, VascuTech radial sheath products, and Scorpion® liver access systems. Additional brokered technologies include ShortCut™ GJ feeding tubes, Thermotex heat therapy systems, Clik-FIX® catheter securement devices, DriPAD™ liquid solidification technology, and FlatCath™ hemodialysis catheters. The company specializes in minimally invasive devices for peripheral, cardiovascular, and oncological disease states.

Differentiator

Problem solved

Functional benefit

Products and services

• Device Incubator Services
• Technology Brokerage
• Consulting Services
• EN Snare Retrieval and Foreign Body Removal System
• Fibrex Catheter Patency Device
• PortIO Implantable Intraosseous Vascular Access Device
• AdVENTage Bone Marrow Aspiration Biopsy System
• VascuTech Medical Radial Sheath Line
• ShortCut GJ Feeding Tube
• Thermotex Far Infrared Heat Therapy Systems
• Scorpion Liver Access Systems
• Clik-FIX Catheter Securement Devices
• DriPAD Technology
• FlatCath Low Profile Hemodialysis Catheter
• SideStep Side Loading Steering Handle
• MorCor Biopsy System

Quantifiable outcome

• EN Snare sold to Merit Medical Systems for $21 million in 2009
• +2 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

19 partnerships are on record, tiered core, major and minor.

• PAVmedcoreStrategic or Co-development Partner · 21 March 2024PAVmed (Nasdaq: PAVM) and Hatch Medical entered into a joint venture agreement to complete technology development and commercialization of the PortIO Implantable Intraosseous Vascular Access Device.
• B. Braun Medical Inc.majorChannel Partner/ Reseller/ Distributor · 27 September 2022Successfully brokered asset sale of Starboard Medical's Clik-FIX Catheter Securement Product Line to B. Braun Medical, Inc.
• Syncro Medical InnovationsmajorStrategic or Co-development Partner · 22 September 2021Hatch Medical and Syncro Medical Innovations partnered to commercialize the advanced Gabriel Feeding Tube technology.
• VascuTech MedicalmajorStrategic or Co-development Partner · 20 October 2020Hatch Medical and VascuTech Medical partnered to commercialize advanced Radial Sheath and Micro-Introducer lines developed with Dr. Jonathan Levine.
• Argon Medical DevicesmajorChannel Partner/ Reseller/ Distributor · 26 June 2019Hatch Medical signed manufacturing and distribution pact with Argon Medical Devices for Scorpion Liver Access Systems and other technologies.
• Merit Medical Systems, Inc.majorChannel Partner/ Reseller/ Distributor · 3 June 2009Hatch Medical sold EN Snare assets to Merit Medical Systems for $21 million. Also acquired Quellent's DriPAD technology.
• Scion Medical Technologies, Inc.majorChannel Partner/ Reseller/ DistributorHB Technologies core-tissue biopsy instrument asset sale to Scion Medical. B. Braun Medical's peripheral and carotid stents assets also sold to Scion Medical.
• Nitinol Devices & Components (NDC)majorChannel Partner/ Reseller/ DistributorPhase One Medical's Optional Vena Cava Filter Platform asset sale to NDC (formerly a J&J company).
• InterV MedicalmajorChannel Partner/ Reseller/ DistributorFlatCath Low profile Hemodialysis Catheter licensed manufacturing and distribution to InterV Medical.
• Endologix, Inc.majorChannel Partner/ Reseller/ DistributorNovatek AAA Stent-graft Patent Portfolio intellectual property sale to Endologix, Inc.
• EndoBar SolutionsminorStrategic or Co-development PartnerHatch Medical retained by EndoBar Solutions to sell Embolotherapy System, Lamina.
• ADN InternationalminorStrategic or Co-development PartnerHatch Medical retained by ADN International to secure commercialization partner for Strome-Blitzer Cytologic Collection Balloon.
• Fixit MedicalminorStrategic or Co-development PartnerHatch Medical retained by Fixit Medical to broker Novel Drainage Catheter Fixation Technology.
• Medical Device Technologies (MD TECH)majorChannel Partner/ Reseller/ DistributorHatch Medical joint venture signed global pact with Medical Device Technologies for manufacturing and distribution.
• Welsh, Flaxman and Gitler, LLCminorImplementation/ SI/ Consulting PartnerIntellectual property attorneys providing patent research and trademark services.
• Physician Advisory CouncilcoreStrategic or Co-development PartnerSix-member panel of world-renowned physicians including interventional radiologists, vascular surgeons, and interventional cardiologists assisting in evaluation of new product opportunities.
• ISO Certified Medical Device Manufacturing FirmscoreImplementation/ SI/ Consulting PartnerNetwork of independent affiliates including manufacturing partners for injection molding, catheter extrusion, and nitinol wire formation.
• University Teaching HospitalsminorImplementation/ SI/ Consulting PartnerClinical research partners providing feasibility testing and product performance assessment.
• Yale UniversityminorStrategic or Co-development PartnerHatch Medical licensed sharps safety technology from Yale University in July 2001.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• The Foundry: The Foundry is a medical device incubator that develops minimally invasive technologies from physician-conceived concepts, structuring joint ventures and licensing arrangements similar to Hatch Medical's incubator model.
• Synecor: Synecor is a medical device incubator focused on developing and commercializing novel interventional and minimally invasive devices, comparable to Hatch Medical's physician-inventor incubation and equity-for-services model.
• ExploraMed: ExploraMed is a medical device incubator founded by serial entrepreneur Mir Imran that incubates physician-conceived minimally invasive devices, sharing equity, expertise, and development resources in a structurally identical model to Hatch Medical.
• BioEnterprise: BioEnterprise was a medical technology business accelerator that supported commercialization of health IT, medical device, and biotech ventures, paralleling Hatch Medical's physician-inventor incubation and commercialization support services.
• Confluent Medical Technologies: Confluent Medical Technologies is a medical device contract developer and manufacturer (CDMO) specializing in nitinol-based interventional devices, offering product development through manufacturing services analogous to Hatch's engineering and manufacturing coordination through ISO-certified partners.

Broad incumbents

• Freudenberg Medical (formerly Vention Medical): Freudenberg Medical is a global medical device CDMO with broad device development and manufacturing capabilities including nitinol and catheter specialties, competing for development and production work that Hatch Medical coordinates among partner manufacturers.

Others

• B. Braun Medical: B. Braun Medical is a recurring acquirer of Hatch-brokered technologies (notably Clik-FIX catheter securement devices and peripheral/carotid stent assets) and a key counterparty in Hatch's brokerage transaction flow.
• Merit Medical Systems: Merit Medical Systems is a strategic acquirer in interventional and peripheral vascular devices and a counterparty in Hatch's largest disclosed transaction (EN Snare asset purchase for $21 million in 2009 and DriPAD acquisition).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/HatchMedical
• Facebookfacebook.com/Hatch-Medical-LLC-143420712464399

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hatch Medical